Skip to main content
Equibles

FEDERATED HERMES, INC.

Position in ANIK — Anika Therapeutics, Inc.

CIK 1056288 PITTSBURGH, PA
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$9,875
+$885 QoQ
Shares Held
675
+8.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#100
of 134 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $277,187,959 across 31 Drug Manufacturers - Specialty & Generic names. ANIK ranks #30 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LQDA
Liquidia Corp
 816,187 $65,074,589
2 INDV
Indivior Pharmaceuticals, Inc.
 1,468,749 $60,262,769
3 ELAN
Elanco Animal Health Inc
 1,543,944 $37,996,460
4 IRWD
Ironwood Pharmaceuticals Inc
 3,231,238 $13,603,511
5 AQST
Aquestive Therapeutics, Inc.
 3,112,561 $12,948,253
6 NBIX
Neurocrine Biosciences Inc
 76,569 $12,904,938
7 ALKS
Alkermes plc.
 221,589 $11,611,263
8 XERS
Xeris Biopharma Holdings, Inc.
 1,434,433 $11,360,709

All Filings in ANIK

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,875 675
2026-03-31 $8,990 620
2025-12-31 $3,776 393
2025-09-30 $3,694 393
2024-09-30 $2,815 114
2024-06-30 $1,367 54
2020-12-31 $415,260 9,175
2020-09-30 $2,849,284 80,511
2020-06-30 $3,024,965 80,174
2020-03-31 $1,040 36